Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast.

Suh WW, Hillner BE, Pierce LJ, Hayman JA.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1054-61.

PMID:
15752884
2.

Incorporating margin status information in treatment decisions for women with ductal carcinoma in situ: a decision analysis.

Wang SY, Kuntz K, Tuttle T, Kane R.

Breast Cancer Res Treat. 2010 Nov;124(2):393-402. doi: 10.1007/s10549-010-1166-7. Epub 2010 Sep 17.

PMID:
20848183
3.

Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situ.

Hayman JA, Kabeto MU, Schipper MJ, Bennett JE, Vicini FA, Pierce LJ.

J Clin Oncol. 2005 Aug 1;23(22):5171-7.

PMID:
16051959
4.

Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.

Delea TE, Karnon J, Smith RE, Johnston SR, Brandman J, Sung JC, Gross PE.

Am J Manag Care. 2006 Jul;12(7):374-86.

5.

Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy.

Amichetti M, Caffo O, Richetti A, Zini G, Rigon A, Antonello M, Arcicasa M, Coghetto F, Valdagni R, Maluta S, Di Marco A.

Eur J Cancer. 1997 Sep;33(10):1559-65.

PMID:
9389915
6.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.

PMID:
17687650
7.

Assessing the cost-effectiveness of postmastectomy radiation therapy.

Marks LB, Hardenbergh PH, Winer ET, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):91-8.

PMID:
10219800
8.

Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.

Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. Epub 2005 Jul 11.

PMID:
16005576
9.

Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.

Dunne C, Burke JP, Morrow M, Kell MR.

J Clin Oncol. 2009 Apr 1;27(10):1615-20. doi: 10.1200/JCO.2008.17.5182. Epub 2009 Mar 2.

PMID:
19255332
10.

Post-operative radiotherapy for ductal carcinoma in situ of the breast.

Goodwin A, Parker S, Ghersi D, Wilcken N.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD000563. doi: 10.1002/14651858.CD000563.pub5. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD000563.

PMID:
19588320
11.

[Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].

Fodor J, Mózsa E, Zaka Z, Polgár C, Major T.

Magy Onkol. 2005;49(3):203, 205-8. Epub 2005 Oct 25. Hungarian.

12.

The influence of young age and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy.

Szelei-Stevens KA, Kuske RR, Yantsos VA, Cederbom GJ, Bolton JS, Fineberg BB.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):943-9.

PMID:
11072149
13.

Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy.

Jiveliouk I, Corn B, Inbar M, Merimsky O.

Oncology. 2009;76(1):30-5. doi: 10.1159/000178162. Epub 2008 Nov 26.

PMID:
19033713
14.

Post-operative radiotherapy for ductal carcinoma in situ of the breast.

Goodwin A, Parker S, Ghersi D, Wilcken N.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD000563. doi: 10.1002/14651858.CD000563.pub6. Review. Update in: Cochrane Database Syst Rev. 2013;11:CD000563.

PMID:
19821272
15.

Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ.

Raldow AC, Sher D, Chen AB, Recht A, Punglia RS.

J Clin Oncol. 2016 Nov 20;34(33):3963-3968. doi: 10.1200/JCO.2016.67.8532. Epub 2016 Sep 30.

PMID:
27621393
16.

Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast.

Hillner BE, Desch CE, Carlson RW, Smith TJ, Esserman L, Bear HD.

J Clin Oncol. 1996 Jan;14(1):70-7.

PMID:
8558224
17.

Cost comparison of radiation treatment options after lumpectomy for breast cancer.

Greenup RA, Camp MS, Taghian AG, Buckley J, Coopey SB, Gadd M, Hughes K, Specht M, Smith BL.

Ann Surg Oncol. 2012 Oct;19(10):3275-81. doi: 10.1245/s10434-012-2546-5. Epub 2012 Aug 1.

PMID:
22851048
18.
19.

The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.

Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, Ballard-Barbash R, Willey SC, Harlan LC.

Cancer. 2005 Nov 1;104(9):1840-8.

20.

Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer.

Gold HT, Do HT, Dick AW.

Cancer. 2008 Dec 1;113(11):3108-15. doi: 10.1002/cncr.23923.

Supplemental Content

Support Center